Torsten Zuberbier

Torsten Zuberbier's AcademicInfluence.com Rankings

Torsten Zuberbier

Medical

#968

World Rank

#1247

Historical Rank

Dermatology

#10

World Rank

#14

Historical Rank

medical Degrees

Torsten Zuberbier

Biology

#5169

World Rank

#7589

Historical Rank

Immunology

#281

World Rank

#292

Historical Rank

biology Degrees

Download Badge

Medical
Biology

Why Is Torsten Zuberbier Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Torsten Zuberbier is a German dermatologist and allergologist. Scientific career After completing his Abitur in 1981, Torsten Zuberbier studied medicine at Free University of Berlin from 1983 to 1990. From 1990 to 1994, he completed his specialist training in the Department of Dermatology at the Virchow Clinic in Berlin, where he also became a senior physician in 1995 and qualified as a professor in 1996 with his work on the topic of differentiation and functional relations in human mast cells.

(See a Problem?)

Torsten Zuberbier's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 * (2008) (3261)
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. (2010) (1448)
The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. (2014) (1106)
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision (2017) (1029)
The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria (2018) (1014)
Chronic rhinosinusitis in Europe – an underestimated disease. A GA2LEN study (2011) (821)
EAACI/GA2LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria (2006) (690)
Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma. (2010) (687)
Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report 1 (2011) (617)
Practical guide to skin prick tests in allergy to aeroallergens (2012) (532)
Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. (2006) (469)
EAACI/GA²LEN/EDF/WAO guideline: management of urticaria (2009) (462)
EAACI/GA2LEN/EDF guideline: management of urticaria (2006) (451)
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (2008) (446)
Sub‐lingual Immunotherapy: World Allergy Organization Position Paper 2009 (2009) (435)
Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report (2006) (434)
A WAO - ARIA - GA²LEN consensus document on molecular-based allergy diagnostics (2013) (375)
C3a and C5a stimulate chemotaxis of human mast cells. (1997) (358)
The EAACI/GA 2 LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update (2015) (348)
Risk of first‐generation H1‐antihistamines: a GA2LEN position paper (2010) (338)
Prevalence of adverse reactions to food in Germany – a population study (2004) (338)
How to assess disease activity in patients with chronic urticaria? (2008) (338)
GA2LEN skin test study I: GA²LEN harmonization of skin prick testing: novel sensitization patterns for inhalant allergens in Europe (2009) (324)
Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase. (2011) (295)
Epidemiology of urticaria: a representative cross‐sectional population survey (2010) (289)
Economic burden of inadequate management of allergic diseases in the European Union: a GA2LEN review (2014) (282)
Patient perspectives on the management of atopic dermatitis. (2006) (266)
Food allergy and non‐allergic food hypersensitivity in children and adolescents (2004) (255)
Viruses and bacteria in acute asthma exacerbations – A GA2LEN‐DARE* systematic review (2010) (252)
GA2LEN skin test study II: clinical relevance of inhalant allergen sensitizations in Europe (2009) (251)
EAACI/GA2LEN/EDF guideline: definition, classification and diagnosis of urticaria (2006) (241)
The definition, diagnostic testing, and management of chronic inducible urticarias – The EAACI/GA2LEN/EDF/UNEV consensus recommendations 2016 update and revision (2016) (241)
1,25‐dihydroxyvitamin D3 promotes IL‐10 production in human B cells (2008) (237)
Standard skin prick testing and sensitization to inhalant allergens across Europe – a survey from the GA2LEN network * (2005) (228)
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. (2012) (224)
Unmet needs in severe chronic upper airway disease (SCUAD). (2009) (200)
Direct Angiotensin II Type 2 Receptor Stimulation Acts Anti-Inflammatory Through Epoxyeicosatrienoic Acid and Inhibition of Nuclear Factor &kgr;B (2010) (194)
Successful treatment of solar urticaria with anti‐immunoglobulin E therapy (2008) (190)
Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence. (2019) (188)
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria (2021) (188)
GA2LEN/EAACI pocket guide for allergen‐specific immunotherapy for allergic rhinitis and asthma (2010) (186)
MACVIA‐ARIA Sentinel NetworK for allergic rhinitis (MASK‐rhinitis): the new generation guideline implementation (2015) (178)
Important research questions in allergy and related diseases: nonallergic rhinitis: a GA2LEN paper (2008) (178)
Diagnosis and Treatment of Urticaria and Angioedema: A Worldwide Perspective (2012) (178)
High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study. (2009) (177)
MeDALL (Mechanisms of the Development of ALLergy): an integrated approach from phenotypes to systems medicine (2011) (166)
Redefinition of the human mast cell transcriptome by deep-CAGE sequencing. (2014) (166)
Acute urticaria: clinical aspects and therapeutic responsiveness. (1996) (164)
IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper☆ (2020) (162)
Pseudoallergen-free diet in the treatment of chronic urticaria. A prospective study. (1995) (156)
Integrated care pathways for airway diseases (AIRWAYS-ICPs) (2014) (155)
Urticaria: current opinions about etiology, diagnosis and therapy. (2007) (151)
Prevalence of chronic urticaria in children and adults across the globe: Systematic review with meta‐analysis (2020) (150)
The German version of the chronic urticaria quality‐of‐life questionnaire: factor analysis, validation, and initial clinical findings (2009) (149)
Mechanisms of the Development of Allergy (MeDALL): Introducing novel concepts in allergy phenotypes (2017) (147)
Anti-Immunoglobulin E Treatment of Patients with Recalcitrant Physical Urticaria (2010) (140)
Allergic rhinitis management pocket reference 2008 * (2008) (138)
Undertreatment of rhinitis symptoms in Europe: findings from a cross‐sectional questionnaire survey (2007) (138)
Guideline for the diagnosis of drug hypersensitivity reactions (2015) (136)
Successful treatment of cholinergic urticaria with anti‐immunoglobulin E therapy (2008) (129)
Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis – A EUFOREA‐ARIA‐EPOS‐AIRWAYS ICP statement (2017) (129)
MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis. (2016) (128)
Insulin allergy: clinical manifestations and management strategies (2008) (127)
Intranasal corticosteroids in allergic rhinitis in COVID‐19 infected patients: An ARIA‐EAACI statement (2020) (124)
ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle (2016) (124)
Sub-Lingual Immunotherapy (2009) (124)
2019 ARIA Care pathways for allergen immunotherapy (2019) (117)
Comparison of the efficacy and safety of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic idiopathic urticaria: a multi‐centre, double‐blind, randomized, placebo‐controlled study (2010) (115)
Acupuncture in Patients With Seasonal Allergic Rhinitis (2013) (113)
Guidelines on the management of IgE-mediated food allergies (2015) (113)
Acquired cold urticaria: clinical picture and update on diagnosis and treatment (2007) (110)
Double-blind crossover study of high-dose cetirizine in cholinergic urticaria. (1996) (110)
The ascomycin macrolactam pimecrolimus (Elidel, SDZ ASM 981) is a potent inhibitor of mediator release from human dermal mast cells and peripheral blood basophils. (2001) (109)
Methodology for development of the Allergic Rhinitis and its Impact on Asthma Guideline 2008 update (2007) (108)
GA2LEN (Global Allergy and Asthma European Network) addresses the allergy and asthma ‘epidemic’ (2009) (108)
Recommendations for assessing Patient‐Reported Outcomes and Health‐Related quality of life in clinical trials on allergy: a GA2LEN taskforce position paper (2010) (108)
Expression and functional activity of the IL-8 receptor type CXCR1 and CXCR2 on human mast cells. (1998) (107)
Time and age trends in smoking cessation in Europe (2019) (107)
Important research questions in allergy and related diseases: 3‐chronic rhinosinusitis and nasal polyposis – a GA2LEN study (2009) (107)
Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study (2007) (107)
Efficacy and safety of subcutaneous allergen-specific immunotherapy with depigmented polymerized mite extract in atopic dermatitis. (2012) (106)
Murine mast cells secrete a unique profile of cytokines and prostaglandins in response to distinct TLR2 ligands (2009) (106)
A WAO — ARIA — GA2LEN consensus document on molecular-based allergy diagnosis (PAMD@): Update 2020☆ (2020) (103)
Chronic urticaria: an internet survey of health behaviours, symptom patterns and treatment needs in European adult patients (2009) (103)
Up-dosing with bilastine results in improved effectiveness in cold contact urticaria (2013) (103)
Effects of a pseudoallergen‐free diet on chronic spontaneous urticaria: a prospective trial (2010) (99)
Efficacy and safety of the interleukin‐1 antagonist rilonacept in Schnitzler syndrome: an open‐label study (2012) (98)
Uncontrolled allergic rhinitis during treatment and its impact on quality of life: a cluster randomized trial. (2010) (98)
Is diet partly responsible for differences in COVID-19 death rates between and within countries? (2020) (96)
Is diet partly responsible for differences in COVID-19 death rates between and within countries? (2020) (96)
Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization Statement (2016) (95)
Control of Pseudomonas aeruginosa skin infections in mice is mast cell-dependent. (2007) (95)
Mast cell lines HMC‐1 and LAD2 in comparison with mature human skin mast cells – drastically reduced levels of tryptase and chymase in mast cell lines (2010) (95)
Prevalence of cholinergic urticaria in young adults. (1994) (94)
GA2LEN skin test study III: Minimum battery of test inhalent allergens needed in epidemiological studies in patients (2009) (94)
Are allergic multimorbidities and IgE polysensitization associated with the persistence or re‐occurrence of foetal type 2 signalling? The MeDALL hypothesis (2015) (93)
Severe Chronic Allergic (and Related) Diseases: A Uniform Approach – A MeDALL – GA2LEN – ARIA Position Paper (2012) (93)
Ragweed sensitization in Europe – GA2LEN study suggests increasing prevalence 1 (2009) (93)
Physical urticarias and cholinergic urticaria. (2014) (92)
Pilot study of mobile phone technology in allergic rhinitis in European countries: the MASK‐rhinitis study (2017) (90)
Urticaria: Collegium Internationale Allergologicum (CIA) Update 2020 (2020) (90)
Definition, aims, and implementation of GA2LEN Urticaria Centers of Reference and Excellence (2016) (89)
Handling of allergen immunotherapy in the COVID‐19 pandemic: An ARIA‐EAACI statement (2020) (88)
MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence (2018) (87)
MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence (2018) (87)
Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology (2019) (87)
Methods report on the development of the 2013 revision and update of the EAACI/GA2 LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria. (2014) (87)
Treatment of allergic rhinitis using mobile technology with real‐world data: The MASK observational pilot study (2018) (86)
Trends in smoking initiation in Europe over 40 years: A retrospective cohort study (2018) (84)
Definition, classification, and routine diagnosis of urticaria: a consensus report. (2001) (83)
Understanding the complexity of IgE-related phenotypes from childhood to young adulthood: a Mechanisms of the Development of Allergy (MeDALL) seminar. (2012) (82)
Pseudoallergic reactions in chronic urticaria are associated with altered gastroduodenal permeability (2004) (82)
How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA‐GA2LEN statement (2011) (82)
The role of interleukin-1 in allergy-related disorders (2012) (81)
Eosinophilic nasal polyps are a rich source of eotaxin, eotaxin-2 and eotaxin-3. (2006) (81)
Development and implementation of guidelines in allergic rhinitis – an ARIA‐GA2LEN paper (2010) (81)
Paving the way of systems biology and precision medicine in allergic diseases: the MeDALL success story (2016) (80)
Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma (2019) (80)
Recommendations for assessing patient‐reported outcomes and health‐related quality of life in patients with urticaria: a GA2LEN taskforce position paper (2011) (80)
Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma (2019) (80)
Hypersensitivity reactions to oxaliplatin: cross-reactivity to carboplatin and the introduction of a desensitization schedule. (2002) (79)
The Allergic Rhinitis and its Impact on Asthma (ARIA) score of allergic rhinitis using mobile technology correlates with quality of life: The MASK study (2018) (78)
Primary care: the cornerstone of diagnosis of allergic rhinitis (2008) (78)
Role of nonallergic hypersensitivity reactions in children with chronic urticaria (1998) (76)
Allergic sensitization to native and heated celery root in pollen-sensitive patients investigated by skin test and IgE binding. (1996) (76)
Clinical relevance is associated with allergen-specific wheal size in skin prick testing (2014) (75)
Chronic urticaria: a patient survey on quality‐of‐life, treatment usage and doctor–patient relation (2009) (75)
Allergen exposure chambers: harmonizing current concepts and projecting the needs for the future – an EAACI Position Paper (2017) (74)
Perspectives in allergen immunotherapy: 2017 and beyond (2018) (74)
The relation between paracetamol use and asthma: a GA2LEN European case–control study (2008) (74)
Aromatic components of food as novel eliciting factors of pseudoallergic reactions in chronic urticaria. (2002) (73)
COVID‐19 pandemic: Practical considerations on the organization of an allergy clinic—An EAACI/ARIA Position Paper (2020) (73)
Specific recommendations for PROs and HRQoL assessment in allergic rhinitis and/or asthma: a GA2LEN taskforce position paper (2010) (71)
Evidence‐based (S3) guideline on topical corticosteroids in pregnancy (2011) (70)
Revisions to the international guidelines on the diagnosis and therapy of chronic urticaria (2013) (69)
Nerve growth factor‐β induces mast‐cell marker expression during in vitro culture of human umbilical cord blood cells (2000) (69)
Work productivity in rhinitis using cell phones: The MASK pilot study (2017) (69)
Daily allergic multimorbidity in rhinitis using mobile technology: A novel concept of the MASK study (2018) (68)
Prevention and control of childhood asthma and allergy in the EU from the public health point of view: Polish Presidency of the European Union (2012) (67)
Cabbage and fermented vegetables: From death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID‐19 (2020) (66)
Executive summary of the methods report for ‘The EAACI/GA2LEN/EDF/WAO Guideline for the Definition, Classification, Diagnosis and Management of Urticaria. The 2017 Revision and Update’ (2018) (66)
Comparative cytokine profile of human skin mast cells from two compartments—strong resemblance with monocytes at baseline but induction of IL‐5 by IL‐4 priming (2004) (65)
Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases (2019) (65)
Muckle–Wells syndrome: clinical and histological skin findings compatible with cold air urticaria in a large kindred (2004) (64)
Frequency of atopic dermatitis and relevance of food allergy in adults in Germany. (2006) (63)
Anti‐FcεRIα serum autoantibodies in different subtypes of urticaria (2000) (63)
Responsiveness and minimal important difference of the urticaria control test (2017) (63)
Topical sodium cromoglicate relieves allergen‐ and histamine‐induced dermal pruritus (2010) (63)
Management of chronic spontaneous urticaria in real life – in accordance with the guidelines? A cross‐sectional physician‐based survey study (2013) (62)
Development and implementation of guidelines in allergic rhinitis – an ARIA-GA 2 LEN paper (2010) (62)
Evidence for a restricted rather than generalized stimulatory response of skin-derived human mast cells to substance P (2005) (61)
German guideline for the management of adverse reactions to ingested histamine (2017) (60)
European Union meets the challenge of the growing importance of allergy and asthma in Europe (2004) (60)
The Consolidated Standards of Reporting Trials (CONSORT) Statement applied to allergen-specific immunotherapy with inhalant allergens: a Global Allergy and Asthma European Network (GA(2)LEN) article. (2011) (59)
Chronic inducible urticaria: A systematic review of treatment options (2018) (59)
Successful treatment of cutaneous mastocytosis and Ménière disease with anti-IgE therapy. (2007) (59)
The Longest Wheal Diameter Is the Optimal Measurement for the Evaluation of Skin Prick Tests (2009) (59)
Impact of native, heat‐processed and encapsulated hazelnuts on the allergic response in hazelnut‐allergic patients (2009) (59)
Efficacy of desloratadine in intermittent allergic rhinitis: a GA2LEN study (2009) (58)
Allergic FcεRI‐ and pseudo‐allergic MRGPRX2‐triggered mast cell activation routes are independent and inversely regulated by SCF (2018) (58)
Long-term response to gluten-free diet as evidence for non-celiac wheat sensitivity in one third of patients with diarrhea-dominant and mixed-type irritable bowel syndrome (2016) (57)
ARIA‐suggested drugs for allergic rhinitis: what impact on quality of life? A GA2LEN Review (2008) (57)
Pharmacovigilance of drug allergy and hypersensitivity using the ENDA–DAHD database and the GA2LEN platform. The Galenda project (2009) (57)
Bronchodilator reversibility in asthma and COPD: findings from three large population studies (2019) (57)
European Symposium on Precision Medicine in Allergy and Airways Diseases: Report of the European Union Parliament Symposium (October 14, 2015) (2015) (57)
Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study (2019) (56)
Results and relevance of critical temperature threshold testing in patients with acquired cold urticaria (2010) (55)
ARIA‐EAACI statement on asthma and COVID‐19 (June 2, 2020) (2020) (55)
Prevalence and clinical characteristics of chronic spontaneous urticaria in pediatric patients (2018) (54)
Night-time sedating H1-antihistamine increases daytime somnolence but not treatment efficacy in chronic spontaneous urticaria: a randomized controlled trial (2014) (54)
ARIA‐EAACI statement on severe allergic reactions to COVID‐19 vaccines – An EAACI‐ARIA Position Paper (2020) (53)
Efficacy of Desloratadine in Persistent Allergic Rhinitis – A GA2LEN Study (2010) (53)
Antihistamine‐resistant urticaria factitia successfully treated with anti‐immunoglobulin E therapy (2010) (52)
Management of urticaria: a consensus report. (2001) (52)
Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA (2016) (52)
Bivalent effect of UV light on human skin mast cells-low-level mediator release at baseline but potent suppression upon mast cell triggering. (2005) (52)
The CONSORT statement checklist in allergen‐specific immunotherapy: a GA2LEN paper (2009) (52)
Spatial distribution of allergenic pollen through a large metropolitan area (2017) (51)
Epidemiologie und Klinik der Kälteurtikaria (1996) (51)
Efficacy and safety of canakinumab in urticarial vasculitis: an open-label study. (2013) (50)
AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation (2016) (50)
Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5) (2016) (49)
Spreading excellence in allergy and asthma: the GA2LEN (Global Allergy and Asthma European Network) project (2005) (48)
Non‐pathogenic commensal Escherichia coli bacteria can inhibit degranulation of mast cells (2008) (48)
Bilastine in allergic rhinoconjunctivitis and urticaria (2010) (47)
Food allergies resulting from immunological cross-reactivity with inhalant allergens (2014) (47)
Assessment of histamine‐releasing activity of sera from patients with chronic urticaria showing positive autologous skin test on human basophils and mast cells (2004) (47)
Benefit of mepolizumab treatment in a patient with chronic spontaneous urticaria (2018) (47)
Enhanced P-selectin expression in chronic and dermographic urticaria. (1997) (47)
A case‐control study of the relation between plasma selenium and asthma in European populations: a GA2LEN project * (2008) (45)
Can on-demand non-sedating antihistamines improve urticaria symptoms? A double-blind, randomized, single-dose study. (2013) (45)
Google Trends terms reporting rhinitis and related topics differ in European countries (2017) (44)
Long‐term management of facial atopic eczema with pimecrolimus cream 1% in paediatric patients with mild to moderate disease (2008) (44)
Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA‐ARIA) ‐ EIP on AHA Twinning Reference Site (GARD research demonstration project) (2018) (44)
Benefit from reslizumab treatment in a patient with chronic spontaneous urticaria and cold urticaria (2018) (43)
Approach to suspected food allergy in atopic dermatitis (2009) (43)
EUFOREA Rhinology Research Forum 2016: report of the brainstorming sessions on needs and priorities in rhinitis and rhinosinusitis. (2017) (42)
The role of allergens and pseudoallergens in urticaria. (2001) (42)
Nrf2-interacting nutrients and COVID-19: time for research to develop adaptation strategies (2020) (42)
Ethanol as a cause of hypersensitivity reactions to alcoholic beverages (2002) (41)
ARIA guideline 2019: treatment of allergic rhinitis in the German health system (2019) (41)
A Comparison of the United States and International Perspective on Chronic Urticaria Guidelines. (2018) (41)
Allergies and COVID‐19 vaccines: An ENDA/EAACI Position paper (2022) (41)
Ultraviolet irradiation induces apoptosis in human immature, but not in skin mast cells. (2003) (41)
Differential effects of new‐generation H1‐receptor antagonists in pruritic dermatoses (1998) (40)
Acquired cold urticaria symptoms can be safely prevented by ebastine (2007) (40)
Allergic Rhinitis and Asthma: A Large Cross-Sectional Study in the United Arab Emirates (2010) (40)
Increased leukotriene production by food additives in patients with atopic dermatitis and proven food intolerance (2001) (40)
Chronic urticaria as a systemic disease. (2014) (40)
The impact of GINA suggested drugs for the treatment of asthma on Health‐Related Quality of Life: a GA2LEN review (2008) (40)
Chronic idiopathic urticaria (CIU) is no longer idiopathic: time for an update (2013) (39)
Pharmacological rationale for the treatment of chronic urticaria with second‐generation non‐sedating antihistamines at higher‐than‐standard doses (2012) (39)
Adaptation and initial results of the Polish version of the GA(2)LEN chronic urticaria quality of life questionnaire (CU-Q(2)oL). (2011) (39)
Modern Approaches to the Diagnosis and Treatment of Cold Contact Urticaria (2010) (39)
Economic Burden of the Inadequate Management of Allergic Rhinitis and Urticaria in Asian Countries Based on the GA2LEN Model (2018) (38)
Establishing the place in therapy of bilastine in the treatment of allergic rhinitis according to ARIA: evidence review (2012) (38)
A loose‐fit coculture of activated keratinocytes and dendritic cell‐related cells for prediction of sensitizing potential (2007) (38)
GM-CSF downmodulates c-kit, FcεRIα and GM-CSF receptor expression as well as histamine and tryptase levels in cultured human mast cells (2001) (38)
Subcutaneous Immunotherapy with a Depigmented Polymerized Birch Pollen Extract – A New Therapeutic Option for Patients with Atopic Dermatitis (2011) (38)
Allergic rhinitis: prevalence and possible risk factors in a Gulf Arab population (2010) (38)
CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis: a SUNFRAIL report (2017) (38)
Quantitative detection of soluble adhesion molecules in sera of melanoma patients correlates with clinical stage. (1996) (37)
Risk factors of adverse reactions to food in German adults (2009) (37)
IL-33 and MRGPRX2-Triggered Activation of Human Skin Mast Cells—Elimination of Receptor Expression on Chronic Exposure, but Reinforced Degranulation on Acute Priming (2019) (37)
Serum manganese superoxide dismutase is a new tumour marker for malignant melanoma (1995) (37)
Severe allergic reactions after COVID-19 vaccination with the Pfizer/BioNTech vaccine in Great Britain and USA (2021) (37)
Omalizumab in the treatment of aspirin-exacerbated respiratory disease. (2015) (36)
Mobile technology in allergic rhinitis: evolution in management or revolution in health and care? (2019) (36)
Diagnostic approach for suspected pseudoallergic reaction to food ingredients (2009) (36)
Expression of mast cell growth modulating and chemotactic factors and their receptors in human cutaneous scars. (2001) (36)
Safety review of phenoxyethanol when used as a preservative in cosmetics (2019) (36)
Chronic urticaria: tools to aid the diagnosis and assessment of disease status in daily practice (2015) (36)
Mast cell and myeloid marker expression during early in vitro mast cell differentiation from human peripheral blood mononuclear cells. (2000) (36)
Efficacy of cetirizine in cholinergic urticaria. (1995) (35)
Burden of chronic urticaria relative to psoriasis in five European countries (2017) (35)
Vorgehen bei vermuteter Nahrungsmittelallergie bei atopischer Dermatitis (2002) (35)
The global impact of the COVID‐19 pandemic on the management and course of chronic urticaria (2020) (35)
Role of Adverse Reactions to Food in Urticaria and Exercise-Induced Anaphylaxis (2002) (35)
Respiratory hypersensitivity reactions to NSAIDs in Europe: the global allergy and asthma network (GA2LEN) survey (2016) (34)
ARIA pharmacy 2018 “Allergic rhinitis care pathways for community pharmacy” (2019) (34)
Personalized pollen‐related symptom‐forecast information services for allergic rhinitis patients in Europe (2013) (34)
ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice (2020) (34)
The Work Productivity and Activity Impairment Allergic Specific (WPAI-AS) Questionnaire Using Mobile Technology: The MASK Study. (2017) (34)
Impact of early diagnosis and control of chronic respiratory diseases on active and healthy ageing (2013) (33)
Yin-Yang of IL-33 in Human Skin Mast Cells: Reduced Degranulation, but Augmented Histamine Synthesis through p38 Activation. (2019) (33)
Phenotypic variability in human skin mast cells (2016) (33)
Effect of CC chemokines on mediator release from human skin mast cells and basophils. (1995) (33)
A combination of wheatflour, ethanol and food additives inducing FDEIA (2002) (31)
A randomized, double-blind, vehicle-controlled study of 1% pimecrolimus cream in adult patients with perioral dermatitis. (2008) (31)
Histamine intolerance in patients with chronic spontaneous urticaria (2016) (31)
Steroid-Sparing Effect of Pimecrolimus Cream 1% in Children with Severe Atopic Dermatitis (2007) (31)
Development of the Angioedema Control Test—A patient‐reported outcome measure that assesses disease control in patients with recurrent angioedema (2019) (31)
XXIV World Allergy Congress 2015 (2016) (31)
The transcription factor profile of human mast cells in comparison with monocytes and granulocytes (2004) (31)
Recommendations for the allergy management in the primary care (2014) (30)
Cost‐intensive, time‐consuming, problematical? How physicians in private practice experience the care of urticaria patients (2012) (29)
The patient’s hay-fever diary: three years of results from Germany (2014) (29)
Differentiation of COVID‐19 signs and symptoms from allergic rhinitis and common cold: An ARIA‐EAACI‐GA2LEN consensus (2021) (29)
Miltefosine inhibits human mast cell activation and mediator release both in vitro and in vivo. (2009) (29)
Most chronic urticaria is food‐dependent, and not idiopathic (1998) (29)
Cost Utility of Omalizumab Compared with Standard of Care for the Treatment of Chronic Spontaneous Urticaria (2015) (29)
Skin type differences in solar‐simulated radiation‐induced oxidative stress (2018) (29)
Use of cetirizine in dermatologic disorders. (1999) (29)
Validation of the Angioedema Control Test (AECT) - a patient reported outcome instrument for assessing angioedema control. (2020) (29)
[Epidemiology and clinical aspects of cold urticaria]. (1996) (28)
Type I sensitization towards patent blue as a cause of anaphylaxis (2003) (28)
Exogenous histamine aggravates eczema in a subgroup of patients with atopic dermatitis. (2009) (28)
Anti-FcepsilonRIalpha serum autoantibodies in different subtypes of urticaria. (2000) (28)
C 3 a and C 5 a Stimulate Chemotaxis of Human Mast Cells (1997) (28)
MRGPRX2 is negatively targeted by SCF and IL‐4 to diminish pseudo‐allergic stimulation of skin mast cells in culture (2018) (28)
Skin mast cells develop non‐synchronized changes in typical lineage characteristics upon culture (2014) (28)
Nerve growth factor-beta induces mast-cell marker expression during in vitro culture of human umbilical cord blood cells. (2000) (28)
MAST CELLS IN SKIN TUBERCULOSIS. AUTHORS' REPLY (1996) (27)
Classification of sensitizing and irritative potential in a combined in-vitro assay. (2010) (27)
Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic (2020) (27)
Retinoic Acid Negatively Impacts Proliferation and MCTC Specific Attributes of Human Skin Derived Mast Cells, but Reinforces Allergic Stimulability (2017) (27)
Allergen and allergy risk assessment, allergen management, and gaps in the European Food Information Regulation (FIR) (2015) (27)
Skin testing with food allergens (2008) (27)
Validation of the Global Allergy and Asthma European Network (GA2LEN) chamber for trials in allergy: Innovation of a mobile allergen exposure chamber (2017) (27)
Clinically relevant outcome measures for assessing disease activity, disease control and quality of life impairment in patients with chronic spontaneous urticaria and recurrent angioedema (2015) (27)
Development and validation of the Cholinergic Urticaria Quality‐of‐Life Questionnaire (CholU‐QoL) (2018) (27)
Long-Term Cultured Human Skin Mast Cells Are Suitable for Pharmacological Studies of Anti-Allergic Drugs Due to High Responsiveness to FcεRI Cross-Linking (2011) (26)
Prevention of signs and symptoms of dermographic urticaria by single‐dose ebastine 20 mg (2009) (26)
740 Characterization of naturally occuring pseudoallergens causing chronic urticaria (1996) (26)
A new dendritic cell type suitable as sentinel of contact allergens. (2008) (26)
Efficacy of broccoli and glucoraphanin in COVID-19: From hypothesis to proof-of-concept with three experimental clinical cases (2020) (25)
Allergen extract‐induced interleukin‐10 in human memory B cells inhibits immunoglobulin E production (2009) (25)
Potential Interplay between Nrf2, TRPA1, and TRPV1 in Nutrients for the Control of COVID-19 (2021) (25)
New biologics in the treatment of urticaria (2018) (25)
Allergological approach to drug hypersensitivity reactions (2008) (24)
A Summary of the New International EAACI/GA(2)LEN/EDF/WAO Guidelines in Urticaria. (2012) (24)
ARIA guideline 2019: treatment of allergic rhinitis in the German health system. (2019) (24)
Klimawandel und Pollenallergie: Städte und Kommunen sollten bei der Bepflanzung des öffentlichen Raums Rücksicht auf Pollenallergiker nehmen (2012) (24)
Histamine releasability of basophils and skin mast cells in chronic urticaria (1996) (24)
Mast cells in the cytokine network: the what, where from and what for (1995) (23)
This Provisional PDF corresponds to the article as it appeared upon acceptance. Fully formatted PDF and full text (HTML) versions will be made available soon. A WAO - ARIA - GA2LEN consensus document on molecular-based allergy diagnostics (2013) (23)
Tamoxifen counteracts the allergic immune response and improves allergen‐induced dermatitis in mice (2010) (23)
Practical guide to skin prick tests in allergy to aeroallergens: some concerns (2012) (23)
Children with Dry Skin and Atopic Predisposition: Daily Use of Emollients in a Participant-Blinded, Randomized, Prospective Trial (2014) (23)
Non-celiac gluten/wheat sensitivity (NCGS)—a currently undefined disorder without validated diagnostic criteria and of unknown prevalence (2018) (22)
An individualized diagnostic approach based on guidelines for chronic urticaria (CU) (2015) (22)
Long‐term reduction in local inflammation by a lipid raft molecule in atopic dermatitis (2010) (22)
Development and implementation of guidelines in allergic rhinitis – an ARIA-GA2LEN paper. (2010) (22)
Allergen immunotherapy in the current COVID-19 pandemic: A position paper of AeDA, ARIA, EAACI, DGAKI and GPA (2020) (21)
Effects of Antihistamines on Innate Immune Responses to Severe Bacterial Infection in Mice (2011) (21)
Sugar is not an aggravating factor in atopic dermatitis. (2001) (21)
Review of the safety of octocrylene used as an ultraviolet filter in cosmetics (2019) (21)
MRGPRX2 is the codeine receptor of human skin mast cells: desensitization via β-arrestin and lack of correlation with the FcεRI pathway. (2020) (21)
Updosing of bilastine is effective in moderate to severe chronic spontaneous urticaria: A real‐life study (2018) (21)
Retinoic acid potentiates inflammatory cytokines in human mast cells: Identification of mast cells as prominent constituents of the skin retinoid network (2015) (21)
Diagnosis and treatment of chronic inducible urticaria (2019) (21)
Care of anaphylaxis among practising doctors (2008) (20)
Definition, aims, and implementation of GA2LEN/HAEi Angioedema Centers of Reference and Excellence (2020) (20)
IL-4 and human skin mast cells revisited: reinforcement of a pro-allergic phenotype upon prolonged exposure (2016) (20)
An efficient method for gene knock‐down by RNA interference in human skin mast cells (2017) (20)
Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies (2016) (20)
Baseline and stimulated turnover of cell surface c‐Kit expression in different types of human mast cells (2006) (20)
GM-CSF downmodulates c-kit, Fc(epsilon)RI(alpha) and GM-CSF receptor expression as well as histamine and tryptase levels in cultured human mast cells. (2001) (20)
Update of the S2k guideline on the management of IgE-mediated food allergies (2021) (20)
Density-equalizing mapping and scientometric benchmarking of European allergy research (2010) (20)
Leitlinie zum Management IgE-vermittelter Nahrungsmittelallergien (2015) (19)
Practical recommendations for the allergological risk assessment of the COVID-19 vaccination – a harmonized statement of allergy centers in Germany (2021) (19)
[GA2LEN (Global Allergy and Asthma European Network)]. (2009) (19)
Omalizumab for the treatment of chronic urticaria (2015) (19)
Cytokines Stimulated by IL-33 in Human Skin Mast Cells: Involvement of NF-κB and p38 at Distinct Levels and Potent Co-Operation with FcεRI and MRGPRX2 (2021) (19)
A systematic review of the role of interleukin-17 and the interleukin-20 family in inflammatory allergic skin diseases (2016) (19)
Practical handling of allergic reactions to COVID-19 vaccines (2021) (19)
Chronic urticaria – What does the new guideline tell us? (2018) (19)
Perioral contact dermatitis caused by L‐carvone in toothpaste (1998) (18)
Urticaria (2003) (18)
Urticarial vasculitis and Schnitzler syndrome. (2014) (18)
Keine Empfehlung für IgG- und IgG4-Bestimmungen gegen Nahrungsmittel (2009) (18)
In‐vivo diagnostic test allergens in Europe: A call to action and proposal for recovery plan—An EAACI position paper (2020) (18)
Successful treatment of hereditary angioedema with bradykinin B2‐receptor antagonist icatibant (2009) (17)
Testosterone exerts selective anti‐inflammatory effects on human skin mast cells in a cell subset dependent manner (2012) (17)
Evaluation of systemic provocation tests in patients with suspected allergic and pseudoallergic drug reactions. (1999) (17)
Development and validation of combined symptom‐medication scores for allergic rhinitis * (2021) (17)
Skin provocation tests may help to diagnose atopic dermatitis (2016) (17)
The European Competence Network on Mastocytosis (2004) (17)
Allergen‐mediated modulation of CD23 expression is interferon‐γ and interleukin‐10 dependent in allergic and non‐allergic individuals (2003) (17)
Comorbidities between nose and skin allergy (2011) (17)
Thymic Stromal Lymphopoietin Promotes MRGPRX2-Triggered Degranulation of Skin Mast Cells in a STAT5-Dependent Manner with Further Support from JNK (2021) (17)
Benzoyl peroxide as a cause of airborne contact dermatitis in an orthopaedic technician (2002) (16)
Important questions in allergy: novel research areas (2008) (16)
Skin involvement as the first manifestation of systemic aspergillosis in patients after allogeneic hematopoietic cell transplantation (2001) (16)
Targeted micronutrition via holo-BLG based on the farm effect in house dust mite allergic rhinoconjunctivitis patients – first evaluation in a standardized allergen exposure chamber (2021) (16)
MI (2-methyl-4-isothiazolin-3-one) contained in detergents is not detectable in machine washed textiles (2018) (16)
Hauttestungen mit Nahrungsmittelallergenen (2008) (16)
Wound Healing Process After Thermomechanical Skin Ablation (2020) (16)
Spices to Control COVID-19 Symptoms: Yes, but Not Only… (2020) (16)
Use of topical steroids is largely restricted by irrational emotional concerns in both patients and physicians (2008) (16)
Nahrungsmittelallergien durch immunologische Kreuzreaktionen (2005) (16)
GM-CSF downregulates expression of tryptase, Fc epsilon RI and histamine in HMC-1 mast cells. (1997) (16)
Mast cell–derived TNF‐α and histamine modify IL‐6 and IL‐8 expression and release from cutaneous tumor cells (2011) (16)
Gastritis Can Cause and Trigger Chronic Spontaneous Urticaria Independent of the Presence of Helicobacter pylori (2018) (15)
CONSENSUS STATEMENT ON THE MANAGEMENT OF URTICARIA (2011) (15)
Allergen-Immuntherapie in der aktuellen Covid-19-Pandemiea, b, c (2020) (15)
First evaluation of a symbiotic food supplement in an allergen exposure chamber in birch pollen allergic patients (2020) (15)
Causes of Urticaria (1998) (15)
Human mast cells in the neurohormonal network: expression of POMC, detection of precursor proteases, and evidence for IgE-dependent secretion of alpha-MSH (2008) (15)
Randomized controlled trial of desloratadine for persistent allergic rhinitis: correlations between symptom improvement and quality of life. (2013) (15)
Human mast cells in the neurohormonal network: expression of POMC, detection of precursor proteases, and evidence for IgE-dependent secretion of alpha-MSH. (2006) (15)
[Urticaria. New developments and perspectives]. (2000) (15)
Therapiemöglichkeiten bei der IgE-vermittelten Nahrungsmittelallergie (2010) (15)
Decreased cutaneous expression of stem cell factor and of the p75NGF receptor in urticaria (2003) (15)
Role of IL‐17 in atopy—A systematic review (2021) (14)
Pharmacotherapy of chronic spontaneous urticaria (2013) (14)
The use of biologicals in cutaneous allergies – present and future (2014) (14)
Nahrungsmittelallergie infolge immunologischer Kreuzreaktivitäten mit Inhalationsallergenen (2014) (14)
The role of IL-17, IL-23 and IL-31, IL-33 in allergic skin diseases. (2020) (14)
Immunoregulation in cutaneous allergy: prevention and control (2012) (14)
Updated evidence‐based (S2e) European Dermatology Forum guideline on topical corticosteroids in pregnancy (2017) (14)
Managing food allergy: GA2LEN guideline 2022 (2022) (14)
Gangliosides enhance IgE receptor-dependent histamine and LTC4 release from human mast cells. (1995) (14)
DIAGNOSE UND THERAPIE PSEUDO-ALLERGISCHER REAKTIONEN DER HAUT DURCH NAHRUNGSMITTEL (1996) (14)
Neues von der internationalen Leitlinie für Diagnostik und Therapie der chronischen Urtikaria (2013) (14)
The allergic emergency – management of severe allergic reactions (2014) (14)
Risk factors for severe reactions in food allergy: Rapid evidence review with meta‐analysis (2022) (14)
Peak nasal inspiratory flow as outcome for provocation studies in allergen exposure chambers: a GA2LEN study (2017) (14)
Intradiurnal patterns of allergenic airborne pollen near a city motorway in Berlin, Germany (2016) (13)
The European Competence Network on Mastocytosis (ECNM). (2004) (13)
Lymphocyte surface markers and cytokines are suitable for detection and potency assessment of skin-sensitizing chemicals in an in vitro model of allergic contact dermatitis: the LCSA-ly (2018) (13)
Validity, reliability, and responsiveness of daily monitoring visual analog scales in MASK‐air® (2021) (13)
[ARIA (Allergic Rhinitis and its Impact on Asthma) achievements in 10 years and future needs]. (2012) (13)
Therapiemöglichkeiten bei der IgE-vermittelten Nahrungsmittel-Allergie (2002) (13)
Colophony‐induced contact dermatitis due to ECG electrodes in an infant (2007) (13)
Measuring patient severity in chronic spontaneous/idiopathic urticaria (CSU/CIU) as categorical health states: efficient and informative? (2014) (13)
Food intake in combination with a rise in body temperature: a newly identified cause of angioedema. (1993) (13)
A Summary of the New International EAACI/GA2LEN/EDF/WAO Guidelines in Urticaria (2012) (13)
Is European legislation killing allergy diagnostics? (2012) (13)
100 Years of Immunotherapy: The Monaco Charter (2012) (12)
Le réseau d’excellence de l’Union Européenne GA 2 LEN (Global Allergy and Asthma European Network) (2009) (12)
Guideline on management of suspected adverse reactions to ingested histamine (2021) (12)
Diagnostisches Vorgehen bei Verdacht auf eine pseudoallergische Reaktion durch Nahrungsmittelinhaltsstoffe (2008) (12)
A novel method to generate monocyte-derived dendritic cells during coculture with HaCaT facilitates detection of weak contact allergens in cosmetics (2016) (12)
Effect of granulocyte macrophage colony‐stimulating factor in a patient with benign systemic mastocytosis (2001) (11)
Biologics for atopic diseases: Indication, side effect management, and new developments (2021) (11)
Vorgehen bei Verdacht auf Unverträglichkeit gegenüber oral aufgenommenem Histamin (2012) (11)
Effects of allergen immunotherapy in the MASK‐air study: a proof‐of‐concept analysis (2021) (11)
Alterations in ganglioside expression during the differentiation of human mast cells (1999) (11)
Current and future therapies for treating chronic spontaneous urticaria (2016) (11)
Face masks suitable for preventing COVID-19 and pollen allergy. A study in the exposure chamber (2021) (11)
Management of anaphylaxis due to COVID‐19 vaccines in the elderly (2021) (11)
Olaparib Desensitization in a Patient with Recurrent Peritoneal Cancer. (2018) (11)
Reactive oxygen species and the bacteriostatic and bactericidal effects of isoconazole nitrate (2013) (11)
What we should learn from the London Olympics. (2013) (11)
Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries? (2020) (10)
Pollen season of European beech (Fagus sylvatica L.) and temperature trends at two German monitoring sites over a more than 30-year period (2016) (10)
Immunophenotypic characterization of peripheral B cells. During short-term immunotherapy with tree pollen allergoid and the immunoadjuvant monophosphoryl lipid A. (2002) (10)
Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries? (2020) (10)
Mast cell transcriptome elucidation: what are the implications for allergic disease in the clinic and where do we go next? (2014) (10)
ARIA‐EAACI care pathways for allergen immunotherapy in respiratory allergy (2021) (10)
Treatment strategies in urticaria (2010) (10)
Technical standards in allergen exposure chambers worldwide – an EAACI Task Force Report (2021) (10)
Real‐life treatment of patients with cholinergic urticaria in German‐speaking countries (2019) (10)
Neue Deklarationspflicht für Nahrungsmittelallergene in Lebensmitteln (2006) (10)
Management von Anaphylaxie-gefährdeten Patienten während der Covid-19-Pandemie (2020) (10)
Skin mast cell phenotypes between two highly divergent cohorts – more pronounced variability within than between groups (2017) (10)
European symposium on precision medicine in allergy and airways diseases: report of the European Union parliament symposium (October 14, 2015). (2015) (10)
Climate change and pollen allergy : cities and municipalities should take people suffering from pollen allergy into account when planting in public spaces (2012) (10)
Is allergy immunotherapy with birch sufficient to treat patients allergic to pollen of tree species of the birch homologous group? (2019) (10)
The safety and tolerability profile of bilastine for chronic urticaria in children (2019) (9)
Fluorescence optical imaging for the detection of potential psoriatic arthritis in comparison to musculoskeletal ultrasound (2019) (9)
Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases-Meeting Report (Part 2). (2019) (9)
Diagnostik und Therapie der Urtikaria (2003) (9)
In-vitro-Diagnostik von Nahrungsmittel-Allergien (2001) (9)
Leitlinie Allergologische Diagnostik von Überempfindlichkeitsreaktionen auf Arzneimittel (2015) (9)
Alternative treatments for chronic spontaneous urticaria beyond the guideline algorithm (2017) (9)
Controversies and challenges in the management of chronic urticaria (2016) (9)
Prospective safety analysis of an ultrarush specific immunotherapy in adults with wasp venom allergy (2006) (9)
Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases-Meeting Report (Part 1). (2019) (9)
Allergologische Diagnostik von Überempfindlichkeitsreaktionen auf Arzneimittel (2008) (8)
MRGPRX2-Mediated Degranulation of Human Skin Mast Cells Requires the Operation of Gαi, Gαq, Ca++ Channels, ERK1/2 and PI3K—Interconnection between Early and Late Signaling (2022) (8)
Teil 1: Klassifikation und Diagnostik der Urtikaria - deutschsprachige Version der internationalen S3-Leitlinie* (2011) (8)
[Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI-AeDA-GPA-DGAKI Position Paper (Pocket-Guide)]. (2020) (8)
Gelatin-induced urticaria and anaphylaxis after tick-borne encephalitis vaccine. (2000) (8)
Non-celiac gluten/wheat sensitivity (NCGS)—a currently undefined disorderwithout validated diagnostic criteria and of unknown prevalence Position statement of the task force on food allergy of the German Society of Allergology and Clinical Immunology (DGAKI) (2018) (8)
MRGPRX2 Is the Codeine Receptor of Human Skin Mast Cells: Desensitization through b -Arrestin and Lack of Correlation with the Fc ε RI Pathway (2021) (8)
Pseudoallergy or nonallergic hypersensitivity (1999) (8)
Technical specifications of the Global Allergy and Asthma European Network (GA2LEN) chamber: a novel mobile allergen exposure chamber (2017) (8)
The role of mobile health technologies in stratifying patients for AIT and its cessation. The ARIA-EAACI perspective. (2021) (8)
Leitlinie zum Vorgehen bei Verdacht auf Unverträglichkeit gegenüber oral aufgenommenem Histamin (2017) (8)
Potential control of COVID-19 symptoms by Nrf2-interacting nutrients with TRPA1 (transient receptor potential ankyrin 1) agonist activity (2020) (8)
Ordinary vibratory angioedema is not generally associated with ADGRE2 mutation. (2019) (8)
FcεRI‐ and MRGPRX2‐evoked acute degranulation responses are fully additive in human skin mast cells (2022) (7)
Diagnosis of drug-induced skin reactions: a future role for computer-aided systems? (2011) (7)
Proposal of 0.5 mg of protein/100 g of processed food as threshold for voluntary declaration of food allergen traces in processed food—A first step in an initiative to better inform patients and avoid fatal allergic reactions: A GA²LEN position paper (2021) (7)
Sulforaphane: from death rate heterogeneity in countries to candidate for prevention of severe COVID-19 (2020) (7)
The distribution of pollen and particulate matter in an urban agglomeration using the city of Berlin as an example (2013) (7)
Atopic dermatitis and allergic rhinitis – do co‐effects in therapy exist? (2012) (7)
Establishing a standardized quality management system for the European Health Network GA2LEN * (2009) (7)
MAST CELLS (1995) (7)
Systematic review protocol to define classical IgE-associated diseases from birth to adolescence: the MeDALL study (2012) (7)
[Diagnosis and therapy of chronic urticaria-what is expected from the revision and update of the international guidelines? A report of the public consensus conference "URTICARIA 2012"]. (2013) (7)
Glutathione exposes sequential IgE-epitopes in ovomucoid relevant in persistent egg allergy. (2013) (7)
Chronic Urticaria (2012) (7)
Therapy of allergic rhinitis in routine care: evidence-based benefit assessment of freely combined use of various active ingredients (2020) (7)
Chronische Urtikaria – Was bringt die neue Leitlinie? (2018) (7)
Anwendung von Biologika bei allergischen und Typ-2- entzündlichen Erkrankungen in der aktuellen COVID-19-Pandemie – ein Positionspapier von AeDA, DGAKI, GPA, ÖGAI, LGAI, ÖGP, ARIA und EAACI (2020) (7)
Verteilung von Pollen und Feinstaub in einem städtischen Ballungsraum am Beispiel der Großstadt Berlin (2013) (7)
Vorgehen bei vermuteter Nahrungsmittelallergie bei atopischer Dermatitis. Positionspapier der Arbeitsgruppe Nahrungsmittelallergie der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAI) (2003) (7)
EAACI/GA2LEN/EDF/WAO-Leitlinie für die Definition, Klassifikation, Diagnose und das Management der Urtikaria — konsentierte, deutschsprachige Übersetzung (2018) (7)
Erfolgreiche Behandlung des hereditären Angioödems mit dem Bradykinin‐B2‐Rezeptor‐Antagonisten Icatibant (2010) (7)
Lokale Kombinationstherapie bei entzündlichen Dermatomykosen (2015) (7)
Neue Deklarationspflicht für Nahrungsmittelallergene in Lebensmitteln : Stellungnahme der Arbeitsgruppe Nahrungsmittelallergie der Deutschen Gesellschaft für Allergologie und klinische Immunologie und des Ärzteverbandes Deutscher Allergologen (2006) (7)
A novel experimental technology for testing efficacy of air purifiers on pollen reduction (2016) (6)
Interleukin-4 (IL-4) enhances and soluble interleukin-4 receptor (sIL-4R) inhibits histamine release from peripheral blood basophils and mast cells in vitro and in vivo (1997) (6)
Birch, grass, and mugwort pollen concentrations and intradiurnal patterns at two different urban sites in Berlin, Germany (2017) (6)
S3‐Leitlinie Urtikaria. Teil 1: Klassifikation und Diagnostik der Urtikaria – deutschsprachige Adaptation der internationalen S3‐Leitlinie (2011) (6)
Skin prick tests to common allergens in adult atopic eczema and rhinitis patients: reproducibility on duplicate and repeated testing. (1993) (6)
Kinetics and tissue repair process following fractional bipolar radiofrequency treatment (2019) (6)
Children with Dry Skin and Atopic Predisposition: Outcome Measurement with Validated Scores for Atopic Dermatitis (2016) (6)
The Classification, Pathogenesis, Diagnostic Workup, and Management of Urticaria: An Update. (2021) (6)
S3‐Leitlinie Urtikaria. Teil 2: Therapie der Urtikaria – deutschsprachige Adaption der internationalen S3‐Leitlinie (2012) (6)
Das elektronische Pollentagebuch (2011) (6)
Influence of glycosphingolipids on the release of histamine and sulfidopeptide leukotrienes from human basophils. (1994) (6)
[Therapy of atopic eczema with calcineurin inhibitors]. (2005) (6)
Anaphylaxis to Mepolizumab and Omalizumab in a Single Patient: Is Polysorbate the Culprit? (2020) (6)
Ernährungsstatus bei erwachsenen Patienten mit atopischer Dermatitis (2002) (6)
Treatment of atopic dermatitis with pimecrolimus – impact on quality of life (2007) (6)
[Local combination therapy of inflammatory dermatomycosis: A review of recommendations in national and international guidelines]. (2015) (6)
Document de consensus WAO–ARIA–GA2LEN sur le diagnostic allergologique moléculaire ☆ (2015) (6)
Heterogeneity of the pharmacologic treatment of allergic rhinitis in Europe based on MIDAS and OTCims platforms (2020) (6)
Fruktosemalabsorption@@@Fructose malabsorption: Stellungnahme der AG Nahrungsmittelallergie in der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAKI) (2010) (6)
In vitro diagnostics and molecular basis of IgE-mediated food allergies. (2009) (6)
Urticaria and the gut. (2020) (5)
Classification of Urticaria (2013) (5)
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update: In collaboration with the World Health Organization, GA(2)LEN and AllerGen [ARIA update 2008: Die allergische rhinitis und ihr einfluss auf das asthma] (2009) (5)
Long-term benefits of targeted micronutrition with the holoBLG lozenge in house dust mite allergic patients (2022) (5)
Risk of sensitization and allergy in Ragweed workers – a pilot study (2014) (5)
Erratum to "IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper" [World Allergy Organ J 13/2 (2020) 100080]. (2021) (5)
Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK‐air® real‐world data (2022) (5)
A case-control study of the relation between plasma selenium and asthma in European populations : a GA 2 LEN project * (2008) (5)
Effective treatment with mepolizumab in a patient with refractory Wells syndrome (2020) (5)
Allergic Rhinitis and its Impact on Asthma (ARIA) 2010 Revision Full Online version - published in the Journal of Allergy and Clinical Immunology (2010) (5)
Nahrungsmittelallergien durch immunologische Kreuzreaktionen Leitlinie der Arbeitsgruppe Nahrungsmittelallergie der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAI) und des Ärzteverbandes Deutscher Allergologen (ÄDA) (2005) (5)
Release of stem cell factor during differentiation of human hacat keratinocytes (1994) (5)
Vorgehen bei vermuteter Nahrungsmittelallergie bei atopischer Dermatitis (2008) (5)
ARIA update 2008: allergic rhinitis and its effect on asthma (2009) (5)
A European survey of management approaches in chronic urticaria in children: EAACI pediatric urticaria taskforce (2021) (4)
The SCF/KIT axis in human mast cells: Capicua acts as potent KIT repressor and ERK predominates PI3K (2022) (4)
Perioral dermatitis (2011) (4)
Apfelallergie – Toleranzentwicklung durch regelmäßigen Konsum allergenarmer Äpfel. Eine Beobachtungsstudie (2020) (4)
Keine Empfehlung für IgG- und IgG 4 - Bestimmungen gegen Nahrungsmittel Leitlinie der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAKI), des Ärzteverbandes Deutscher Allergologen (ÄDA), der Gesellschaft für Pädiatrische Allergologie und Umwelt- medizin (GPA), der Österreichis (2009) (4)
[Food intolerance. II]. (1993) (4)
Integration of the human dermal mast cell into the organotypic co-culture skin model. (2014) (4)
Allergies and the skin, an interdisciplinary approach in GA2LEN and EAACI activities (2006) (4)
Diagnostik der Urtikaria (1996) (4)
Available and affordable complementary treatments for COVID‐19: From hypothesis to pilot studies and the need for implementation (2022) (4)
Allergen immunotherapy in MASK‐air users in real‐life: Results of a Bayesian mixed‐effects model (2022) (4)
Antihistamines in the treatment of urticaria. (2010) (4)
[GA(2)LEN (Global Allergy and Asthma European Network): European network of excellence for asthma and allergic diseases]. (2009) (4)
Testing for cattle allergy: modified diagnostic cutoff levels improve sensitivity in symptomatic claw trimmers (2010) (4)
Atopic skin is associated with a lack of phosphatidylcholine-sphingomyelin transacylase activity. (2007) (4)
Atopic Patients Show Increased Interleukin 4 Plasma Levels but the Degree of Elevation Is Not Sufficient to Upregulate Interleukin-4-Sensitive Genes (2019) (4)
Prevalence and risk factors of chronic urticaria in China: A nationwide cross‐sectional study (2022) (4)
Gastrointestinal barrier in patients with chronic recurrent urticaria: Effect of a low-pseudoallergen diet* (1998) (4)
ARIA-Leitlinie 2019: Behandlung der allergischen Rhinitis im deutschen Gesundheitssystem (2019) (4)
Tannin inhibits histamine release (1999) (4)
Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5) (2017) (4)
High response rate to additive‐free diet in chronic urticaria (1996) (4)
Noninvasive measures in atopic dermatitis (2018) (4)
Der allergologische Notfall – Management der Anaphylaxie (2014) (4)
Vorgehen bei vermuteter Nahrungs mittelallergie bei atopischer Dermatitis Leitlinie der Arbeitsgruppe Nahrungsmittelallergie der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAKI), des Ärzteverbandes Deutscher Allergologen (ÄDA) und der Gesellschaft für Pädiatrische Allergolog (2008) (4)
Keine Empfehlung für IgG- und IgG4- (2009) (4)
Acute and Chronic Urticaria (1998) (3)
Therapeutische Alternativen bei Antihistamintherapie-refraktärer Urtikaria (2010) (3)
Reply to correspondence to ‘Differentiation of COVID‐19 signs and symptoms from allergic rhinitis and common cold: An ARIA‐EAACI‐GA2LEN consensus’ (2022) (3)
Experience‐based advice on stepping up and stepping down the therapeutic management of chronic spontaneous urticaria: Where is the guidance? (2022) (3)
Standardisierung von oralen Provokationstests bei Nahrungsmittelallergien (2006) (3)
Aktuelle Empfehlungen zur praktischen Durchführung von SCIT und SLIT (2006) (3)
Die Arbeitsgemeinschaft Allergologie in der DDG (2014) (3)
Aromastoffe — Bisher unbekannte Auslöser von Nahrungsmittelpseudoallergien bei chronischer Urtikaria (1998) (3)
Lymphocyte surface markers and cytokines are suitable for detection and potency assessment of skin-sensitizing chemicals in an in vitro model of allergic contact dermatitis: the LCSA-ly (2018) (3)
A visit to the mother in law – a hidden cause for urticaria (2007) (3)
In-vitro migratory response of human mast cells towards zymosan-activated serum and interleukins (1994) (3)
Academic productivity of young people with allergic rhinitis: A MASK-air® study. (2022) (3)
Instrumente zur Erfassung von Krankheitsaktivität, Krankheitskontrolle und Lebensqualitätsbeeinträchtigung bei Patienten mit chronischer Urtikaria und Angioödemen (2016) (3)
White paper on peanut allergy – part 1: Epidemiology, burden of disease, health economic aspects (2021) (3)
Elicitors and phenotypes of adult patients with proven IgE‐mediated food allergy and non‐immune‐mediated food hypersensitivity to food additives (2022) (3)
Zur Deklaration „versteckter Allergene“ in Lebensmitteln (2001) (3)
β-arrestin-1 and β-arrestin-2 Restrain MRGPRX2-Triggered Degranulation and ERK1/2 Activation in Human Skin Mast Cells (2022) (3)
Dietary implications in acetylsalicylic acid intolerance (2020) (3)
Update Leitlinie zum Management IgE-vermittelter Nahrungsmittelallergien – S2k-Leitline der DGAKI (2021) (3)
Positionspapier: Hinweise zur Patienteninformation und -aufklärung vor Anwendung von Biologika bei chronischer Rhinosinusitis mit Polyposis nasi (CRSwNP) – Empfehlungen des Ärzteverbandes Deutscher Allergologen (AeDA) und der Deutschen Gesellschaft für HNO-Heilkunde, Kopf- und Halschirurgie (DGHNOKH (2020) (3)
[The Working Group on Allergology in the DDG]. (2014) (3)
Anwendung von Biologika bei allergischen und Typ-2-entzündlichen Erkrankungen in der aktuellen Covid-19-Pandemiea, b, c (2020) (3)
Cytokine Stimulation via MRGPRX2 Occurs with Lower Potency than by FcεRI-aggregation but with Similar Dependence on the ERK1/2 Module in Human Skin Mast Cells. (2021) (3)
Comparison of rhinitis treatments using MASK‐air® data and considering the minimal important difference (2022) (3)
Automatic screening of self‐evaluation apps for urticaria and angioedema shows a high unmet need (2021) (3)
The prevalence and year lived with disability of atopic dermatitis in China: Findings from the global burden of disease study 2019 (2021) (3)
Phlebologie an deutschen Hautkliniken (2013) (3)
Diagnosis of Urticaria (1998) (3)
In Subjects with Persistent Allergic Rhinitis (PER) Treated with Desloratadine, Improvements in Total 5-Symptom Scores (T5SS) and Rhinoconjunctivitis Quality of Life Questionnaire-Standardized (RQLQ-S) Correlate with Disease Burden as Measured using a Simple Visual Analog Scale (VAS) (2009) (3)
Systematic review of monotherapy with biologicals for children and adults with IgE‐mediated food allergy (2022) (3)
Identification by cluster analysis of patients with asthma and nasal symptoms using the MASK-air® mHealth app. (2022) (3)
ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines -- an EAACI-ARIA Position Paper (2020) (3)
Dermographic urticaria symptoms can be safely prevented by ebastine (2007) (3)
Economic Burden of Chronic Spontaneous Urticaria And Psoriasis: Patients Perspective From Europe. (2015) (3)
Untreated allergic rhinitis is a major risk factor contributing to motorcar accidents (2019) (3)
Correction to: Guideline for the diagnosis of drug hypersensitivity reactions (2018) (3)
Classification of urticaria. (2013) (3)
EUFOREA Rhinology Research Forum 2017: report of the brainstorming sessions on endotype-driven treatment, patient empowerment and digital future in airways care (2018) (3)
Unsaturated compounds induce up-regulation of CD86 on dendritic cells in the in vitro sensitization assay LCSA (2016) (3)
Real‐world data using mHealth apps in rhinitis, rhinosinusitis and their multimorbidities (2022) (2)
Occupational contact dermatitis from ninhydrin in a police officer (2010) (2)
Erratum to: Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA (2016) (2)
Die Rolle pseudoallergischer Nahrungsmittelunverträglichkeiten in der Dermatologie : Spezielle Erfordernisse in der Diagnostik pseudoallergischer Nahrungsmittel-unverträglichkeitsreaktionen (2000) (2)
Omalizumab in IgE-mediated food allergy: A systematic review and meta-analysis. (2022) (2)
Guideline on Lichen sclerosus (2014) (2)
Effects of a Novel GA2LEN Training Program on Urticaria on the Knowledge of General Practitioners in Saudi-Arabia (2011) (2)
Hand-Fuß-Syndrom bei Tyrosinkinaseinhibitortherapie (2013) (2)
Specific immunotherapy with allergens: an important tool in the treatment of the allergic diseases (2012) (2)
Celecoxib desensitization: continued temozolomide/celecoxib chemotherapy after a celecoxib-induced hypersensitivity reaction. (2012) (2)
Usage patterns of oral H1-antihistamines in 10 European countries: A study using MASK-air® and Google Trends real-world data (2022) (2)
[Phlebology in German departments of dermatology. An analysis on behalf of the German Society of Phlebology]. (2013) (2)
The ARIA approach of Value-Added Medicines: as-needed treatment in allergic rhinitis. (2022) (2)
Diätetische Implikationen bei ASS-Unverträglichkeit (2020) (2)
Versorgungsprofil von Patienten mit schweren allergischen Reaktionen (2011) (2)
Kostenintensiv, zeitaufwendig, problematisch? – Die Betreuung von Urtikariapatienten aus der Perspektive niedergelassener Årzte (2012) (2)
Therapie von Patienten mit cholinergischer Urtikaria im Alltag in deutschsprachigen Ländern (2019) (2)
Human Mast Cells IL-8 Receptor Type CXCR 1 and CXCR 2 on Expression and Functional Activity of the (1998) (2)
Consistent trajectories of rhinitis control and treatment in 16,177 weeks: The MASK‐air® longitudinal study (2022) (2)
IgE Downmodulates Stem Cell Factor–Driven Mast Cell Development from Cultured Peripheral Blood Mononuclear Cells (1999) (2)
Neue Urtikaria-Leitlinie — ein europäisches Empfehlungsgerüst (2011) (2)
Loss of food fermentation in Westernized diet: a risk factor for severe COVID-19? (2020) (2)
[Food intolerance. Part I]. (1992) (2)
GA2LEN (Global Allergy and Asthma European Network), die Perspektive der deutschsprachigen Zentren (2009) (2)
Diagnostik und Therapie der chronischen Urtikaria – Was wird von Revision und Aktualisierung der internationalen Leitlinie erwartet? (2013) (2)
Schwere allergische Reaktionen nach COVID-19-Impfung mit dem Impfstoff von Pfizer/BioNTech in Großbritannien und USA (2021) (2)
Presentation of airway and general symptoms in COVID‐19 caused by dominant SARS‐CoV‐2 variants: A follow‐up on ARIA consensus (2022) (2)
Comparison of the efficacy and safety of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic idiopathic urticaria : a multi-centre , double-blind , random-ized , placebo-controlled study (2010) (2)
Reply [to letters from Dr. Chipps and Dr. Spector] (2011) (2)
[ARIA (Allergic Rhinitis and its Impact on Asthma). Achievements in 10 years and future needs in Latin America]. (2013) (2)
Wytyczne EAACI/GA2LEN/EDF/WAO dotyczące definicji, klasyfikacji, diagnostyki i leczenia pokrzywki (2020) (2)
In-vitro-Diagnostik von Nahrungsmittelallergien. Positionspapier der Deutschen Gesellschaft für Allergie und Klinische Immunologie (DGAKI) und des Ärzteverbandes Deutscher Allergologen (ÄDA) / In vitro diagnostics in food allergy. Position paper of the German Society of Allergy and Clinical Immunolo (2007) (2)
Diagnosis and Treatment of Melanoma. European Consensus ⴀbased Interdisciplinary Guideline Developed by the Guideline Subcommittee of the (2012) (2)
Positionspapier: Hinweise zur Patienteninformation und -aufklärung vor Anwendung von Biologika bei chronischer Rhinosinusitis mit Nasenpolypen (CRSwNP) – Teil 2: Omalizumab – Empfehlungen des Ärzteverbandes Deutscher Allergologen (AeDA) und der Deutschen Gesellschaft für HNO-Heilkunde, Kopf- und Hal (2021) (2)
2020 ARIA CARE PATHWAYS FOR ALLERGIC RHINITIS - GEORGIA. (2019) (2)
Inhaled corticosteroids in early COVID‐19—A tale of many facets (2021) (2)
Sensibilierungen gegenüber inhalativen Allergenen in Europa: Ergebnisse der GA²LEN Pricktest-Studien (2012) (2)
Evanescence wave-based technology for the rapid and sensitive quantification of biological analytes. (2017) (2)
Technical specifications of the Global Allergy and Asthma European Network (GA2LEN) chamber: a novel mobile allergen exposure chamber (2017) (2)
Die chronische Rhinosinusitis in Europa: eine Zusammenfassung epidemiologischer Arbeiten von GA²LEN (2012) (2)
Allergen immunotherapy in the current COVID-19 pandemic - A position paper of the AeDA, ARIA, EAACI, DGAKI and GPA (2020) (2)
Nahrungsmittelunverträglichkeiten : Übersicht - Prävalenz (2000) (2)
CREB Is Activated by the SCF/KIT Axis in a Partially ERK-Dependent Manner and Orchestrates Survival and the Induction of Immediate Early Genes in Human Skin Mast Cells (2023) (1)
Guideline on Photodynamic Therapy (2014) (1)
A case-control study of the relation between plasma selenium and asthma in European populations: A GA 2 LEN project (Allergy: European Journal of Allergy and Clinical Immunology (2008) 63, (865-874)) (2008) (1)
Die Therapie der allergischen Rhinitis in der Routineversorgung: evidenzbasierte Nutzenbewertung der kombinierten Anwendung mehrerer Wirkstoffe (2020) (1)
Antihistamines in atopic dermatitis (2007) (1)
Development and validation of an electronic daily control score for asthma (e-DASTHMA): a real-world direct patient data study. (2023) (1)
Actions to take when suspecting a pseudo-allergic reaction caused by food components: joint position paper from DGAI and ÄDA. (2000) (1)
Allergological diagnostics of hypersensitivity reactions to drugs (2008) (1)
Pollenassoziierte Nahrungsmittelallergien : Orales Allergie-Syndrom (2000) (1)
Nicht-Zöliakie-Gluten-/Weizen-Sensitivität (NCGS) — ein bislang nicht definiertes Krankheitsbild mit fehlenden Diagnosekriterien und unbekannter Häufigkeit (2018) (1)
Nutzen von Mepolizumab bei einer Patientin mit chronischer spontaner Urtikaria (2018) (1)
Correction to “ARIA guideline 2019: treatment of allergic rhinitis in the German health system” (2020) (1)
Sublingual immunotherapy (2006) (1)
Erratum to: Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization Statement (2017) (1)
Ursachen der Urtikaria (1996) (1)
Efficacy of Desloratadine in Persistent Allergic Rhinitis -- A GAtextsuperscript2LEN Study (2010) (1)
Nonpharmacological measures to prevent allergic symptoms in pollen allergy: A critical review (2021) (1)
[Current recommendations for the use of SCIT and SLIT]. (2006) (1)
Gene expression and regulation of transcription factor activator protein‐2 alpha in human mast cells (2005) (1)
Therapiemöglichkeiten bei der IgE- vermittelten Nahrungsmittel-Allergie Positionspapier der Arbeitsgruppe Nahrungsmittel-Allergie der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAI) und des Ärzteverbandes Deutscher Allergologen (ÄDA) (2002) (1)
Up-dosing of Desloratadine Reduces Cold Provocation Test Responses in Patients with Cold Urticaria (2008) (1)
PRISE EN CHARGE DE LA RHINITE ALLERGIQUE GUIDE DE POCHE DE REFERENCE 2007 (2008) (1)
Praktischer Umgang mit allergischen Reaktionen auf COVID-19-Impfstoffe (2021) (1)
Allergologische Diagnostik von Überempfindlichkeitsreaktionen auf Arzneimittel / Allergological approach to drug hypersensitivity reactions Leitlinie der Deutschen Dermatologischen Gesellschaft (DDG) und der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAKI) in Zusammenarbeit (2008) (1)
Das europäische Curriculum für die Zusatzbezeichnung Allergologie (2021) (1)
Update „Urtikaria“ (2010) (1)
Pädiatrische Allergologie und Umweltmedizin e.V. Leitlinie der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAKI), der Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA) und des Ärzteverbandes Deutscher Allergologen (ÄDA) (2012) (1)
Influence of IL-4 on histamine release from human skin mast cells (1994) (1)
Effects of Exposure to New Car Interiors in Patients With Asthma and Allergic Rhinitis (2018) (1)
Verstecktes Risiko im Kleingedruckten? (2016) (1)
The Personalized Treatment for Urticaria (2015) (1)
Allergen- und Allergierisikobewertung, Allergenmanagement und Lücken der europäischen Lebensmittelinformationsverordnung (LMIV) (2015) (1)
Diagnostic dilemmas in chronic urticaria (2015) (1)
ROLE OF FOOD IN URTICARIA (2007) (1)
In-vitro-Diagnostik von Nahrungsmittel-Allergien: Positionspapier der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAI) und des Ärzteverbandes deutscher Allergologen (ÄDA) (2002) (1)
Die allergische Rhinitis und ihre Bedeutung für das Asthma: Update (ARIA 2008). Eine Bestandsaufnahme aus deutscher Sicht (2008) (1)
Testing bronchodilator responsiveness (2019) (1)
Digital Health Europe (DHE) Twinning on severe asthma—kick-off meeting report (2021) (1)
[Hand-foot syndrome with tyrosine kinase inhibitor therapy: treatment recommendations]. (2013) (1)
Digitally‐enabled, patient‐centred care in rhinitis and asthma multimorbidity: The ARIA‐MASK‐air® approach (2023) (1)
Rapid TRP (transient receptor potential) desensitization in COVID-19: fact or fancy? (2020) (1)
Chemokine Expression-Based Endotype Clustering of Chronic Rhinosinusitis (2022) (1)
Diversities of allergic pathologies and their modifiers: Report from the second DGAKI-JSA meeting. (2022) (1)
Birch, grass, and mugwort pollen concentrations and intradiurnal patterns at two different urban sites in Berlin, Germany (2017) (1)
Comparison of Mast Cell Precursors and Cultured Mast Cells from the Cord Blood of Children with Atopic and Nonatopic Parents (2001) (1)
Skin type differences in sun‐induced oxidative stress (2019) (1)
The role of biologics in pediatric food allergy and eosinophilic gastrointestinal disorders. (2023) (1)
[Nutritional status of adult patients with atopic dermatitis]. (2002) (1)
Chronische Urtikaria: diagnostisches und therapeutisches Vorgehen (1993) (1)
Decrease in Burden of Disease, as Measured on a Simple Visual Analog Scale, Correlates Significantly with Improvements in Total Symptom Score and Quality of Life in Desloratadine-treated Subjects with Intermittent Allergic Rhinitis: Results of the ACCEPT1 Study (2009) (1)
Legends of allergy and immunology: Jean Julien Raoul Bousquet; a Chemist, a Pharmacist, a Biologist, a Physician and—above all—an innovative scientist (2020) (1)
Allergologische Diagnostik von Überempfindlichkeitsreaktionen auf Arzneimittel Leitlinie der Deutschen Dermatologischen Gesellschaft (DDG) und der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAKI) in Zusammenarbeit mit dem Ärzteverband Deutscher Allergologen (ÄDA) und dem Ber (2008) (0)
International Symposium “Mast Cells and Cellular Interactions” Berlin, Kaiserin-Friedrich-Stiftung, September 15–16, 1995 (1995) (0)
Subject Index Vol. 155, 2011 (2011) (0)
Impact of Atopic Dermatitis on Quality of Life and Patient Attitudes Towards Current Management Options (2006) (0)
Development and implementation of guidelines in allergic rhinitis - an ARIA-GA2LEN paper RID F-1148-2011 RID B-7562-2008 RID D-4375-2009 (2010) (0)
Annular urticarial lesions. (2021) (0)
S1-1 Antihistamine therapy-The perspective of international guidelines(Antihistamine update (English Session)) (2013) (0)
[Indoor allergens]. (2001) (0)
5th Meeting of the ‘Endocrine Dermatology’ Group of the Arbeitsgemeinschaft Dermatologische (2006) (0)
Acknowledgment to Referees for Dermatology 1996 (1996) (0)
Contents Vol. 153, 2010 (2010) (0)
Expression and function of cannabinoid receptors on human dermal mast cells (1998) (0)
Effect of UV-light on apoptosis of human mast cells (2002) (0)
71 Glutathione Exposed Sequential Epitopes of Ovomucoid Are Relevant for Persistent Egg-Allergic Patients (2012) (0)
Guideline on Steroids in Pregnancy (2010) (0)
for treatment of tree allergic patients with (2019) (0)
S3 Guideline Urticaria. Part 2: Treatment of urticaria – German‐language adaptation of the international S3 guideline (2023) (0)
WS069 The pathophysiology of mastocytosis (1997) (0)
Chronic urticaria: from thyroid autoimmunity to Helicobacter pylori. Authoir's reply (2004) (0)
Edward Nettleship (1845–1913) (2008) (0)
Prevalence and risk factors of allergic rhinitis among Chinese adults: A nationwide representative cross-sectional study (2023) (0)
Update of the Guideline on Chronic Urticaria (2014) (0)
Development of tripe palms and soles in a patient with long pre‐existing systemic mastocytosis and newly developed non‐small cell lung cancer (2018) (0)
Chronic spontaneous urticaria guidelines: What is new? (2022) (0)
Global Multidisciplinary Networks (2019) (0)
Contents Vol. 155, 2011 (2011) (0)
Reply to Ensina et al (2018) (0)
Effects Of Exposure To New Car Interiors On Patients With Asthma And Allergic Rhinitis (2018) (0)
From Molecular Science to the Treatment of Allergy (1999) (0)
Subject Index Vol. 151, 2010 (2010) (0)
Skin allergy. (2017) (0)
Celebrating the case study: Schloss’ description of atopic dermatitis (2013) (0)
769 Murine skin mast cells release histamine after stimulation with vanilloids In vitro (1996) (0)
Automated Evaluation Of Conjunctival Provocation Tests (2014) (0)
Validation of the GA(2)LEN chamber for trials in allergy Innovation of a mobile allergen exposure chamber Allergy and Asthma (0)
Wytyczne EAACI/GA2LEN/EDF/WAO dotyczące definicji, klasyfikacji, rozpoznawania i leczenia pokrzywki: weryfikacja z 2013 roku z poprawkami (2015) (0)
Rev Mal Respir, 26 (2009), 577 (2009) (0)
Extension of mepolizumab injection intervals as potential of saving costs in well controlled patients with severe eosinophilic asthma (2022) (0)
Inheritance Of Tryptase Genes With Loss-Of-Function Mutations Correlates With Reduced Tryptase Activity In Human Skin Mast Cells (2012) (0)
Skin physiology, mucosal functions and symptoms are modulated by grass pollen and ozone double exposure in allergic patients. (2023) (0)
EVS5-5 A patient focused approach in the treatment of Atopic Dermatitis (2013) (0)
Omalizumab in the Treatment of Urticaria (2021) (0)
Patient-centred digital biomarkers for allergic respiratory diseases and asthma: the ARIA-EAACI approach. (2023) (0)
A Summary of the New International EAACI/GA2LEN/EDF/WAO Guidelines in Urticaria (2012) (0)
Guideline on Lichen sclerosus Developed by the Guideline (2014) (0)
Unsaturated compounds induce up-regulation of CD86 on dendritic cells in the in vitro sensitization assay LCSA (2015) (0)
Tricks und Fallen des plazebokontrollierten oralen Provokationstests (2002) (0)
Temporal trends in smoking cessation in Europe from 1980 to 2010 (2017) (0)
Comprar Urticaria and Angioedema | Zuberbier, Torsten | 9783540790471 | Springer (2010) (0)
Therapy of urticaria: German language version of the international S3-guideline (2012) (0)
Classification and Diagnosis of Urticaria (2021) (0)
[Risk hidden in the small print? : Some food additives may trigger pseudoallergic reactions]. (2016) (0)
Erratum to: A novel method to generate monocyte-derived dendritic cells during coculture with HaCaT facilitates detection of weak contact allergens in cosmetics (2016) (0)
GA²LEN study: prevalence of chronic rhinosinusitis in Europe by EP3OS criteria (2010) (0)
Management Principles in Urticaria (2021) (0)
Trends in smoking habits in Europe: Are anti-smoking policies overlooking pre-adolescents? (2016) (0)
A novel experimental technology for testing efficacy of air purifiers on pollen reduction (2017) (0)
Review article Insulin allergy: clinical manifestations and management strategies (2008) (0)
S3 Guideline Urticaria. Part 1: Classification and diagnosis of urticaria – German‐language adaptation of the international S3 Guideline (2023) (0)
Subject Index Vol. 153, 2010 (2010) (0)
Syddansk Universitet Validation of the GA ( 2 ) LEN chamber for trials in allergy Innovation of a mobile allergen exposure chamber (0)
Cut-off values of MASK-air® Patient-Reported Outcome Measures (PROMs). (2022) (0)
Acute Urticaria (2021) (0)
Chapter-02 Classification of Urticaria (2018) (0)
Sequential IgE-epitopes of ovomucoid exposed by glutathione are relevant in persistent egg allergy (2013) (0)
IL3 Global trends in management of urticaria and allergic rhinitis (2012) (0)
[Diagnosis of allergies]. (2003) (0)
[Differences in the groups of chronic urticaria as explanation of divergent results in the search for etiology]. (2001) (0)
Clinical review: The suggested management pathway for urticaria in primary care (2022) (0)
Other Interventions for Chronic Urticaria (2021) (0)
Reply (2004) (0)
Erratum to: A novel method to generate monocyte-derived dendritic cells during coculture with HaCaT facilitates detection of weak contact allergens in cosmetics (2016) (0)
Chronic urticaria - why are patients dissatisfied with treatment? (2007) (0)
Prevention of signs and symptoms of cold urticaria by ebastine (2007) (0)
Anti-proliferative effect of histamine on squamous cell carcinoma of the skin and downregulation of vascular endothelial growth factor receptor-2 (2018) (0)
Contents Vol. 215, 2007 (2007) (0)
Development and Validation of an Electronic Daily Control Score for Asthma (e-DASTHMA) (2022) (0)
535 Tryptase up regulate VEGF and PDGF in squamous cell carcinoma cells (SCC) (2010) (0)
Treatment of allergic rhinitis using mobile technology with real world data (2018) (0)
What is new and upcoming in the world of chronic urticaria? (2016) (0)
[Added information and corrections on the continuing education section "Indoor allergens"]. (2002) (0)
Integration of the Human Dermal Mast Cell into the Organotypic Co-culture Skin Model. (2020) (0)
[10 minute consultation: urticaria]. (2004) (0)
329 Interleukin-4 enhances and soluble interleukin-4 receptor inhibits histamine release from peripheral blood basophils and mast cells in vitro and in vivo (1996) (0)
IL6 Inducible urticaria : A wide spectrum and high need for individual approaches in management (2013) (0)
Developing integrated care pathways for atopic dermatitis—Challenges and unmet needs (2023) (0)
Kimchi and Asian fermented vegetables: candidates for the partial control of the COVID-19 pandemic (2020) (0)
Humanistic Burden of Chronic Spontaneous Urticaria in Comparison to Psoriasis: European Perspective. (2015) (0)
Answer to the letter to the editor titled ‘Phenoxyethanol, reproduction, and development: additional studies are needed’ (2020) (0)
[Sublingual immunotherapy. Where are we now?]. (2011) (0)
Antihistamines in Atopic Eczema (2006) (0)
MeDALL (Mechanizmy powstawania alergii): Zintegrowane podejście - od fenotypów do medycyny systemowej (2011) (0)
Efficacy and safety of medications for antihistamine-refractory chronic spontaneous urticaria: a systematic review and network meta-analysis (2022) (0)
Subject Index Vol. 193, 1996 (1996) (0)
A real-life comparison of pulmonary and nasal outcomes in patients with severe asthma and nasal polyposis treated with T2-biologics (2023) (0)
Successful simultaneous targeting of IgE and IL-5 in a severe asthmatic patient selected for lung transplantation (2022) (0)
[Screening procedures in the family practice. What is the new fast allergy test?]. (2004) (0)
Eotaxin-, Eotaxin-2-, Eotaxin-3- und RANTES- Proteinsynthese bei Polyposis nasi : Korrelation zu Eosinophilie und Ätiologie (2006) (0)
Diagnostik bei atopischem Ekzem (2005) (0)
Erfolgreiche Behandlung mit Mepolizumab bei einem Patienten mit therapieresistentem Wells‐Syndrom (2020) (0)
Poster (2007) (0)
Dem Geheimnis der Urtikaria auf der Spur (2006) (0)
Subject Index Vol. 215, 2007 (2007) (0)
Improvement of daily allergy control by sublingual immunotherapy: A MASK-air® study. (2023) (0)
15. Mainzer Allergie-Workshop 2003 (2003) (0)
Allergien in den Griff bekommen: Frühzeitig behandeln — Spätfolgen vermeiden (2013) (0)
Biologika bei atopischen Erkrankungen: Indikationsstellung, Nebenwirkungsmanagement und neue Entwicklungen (2021) (0)
17in atopic dermatitis (2007) (0)
Therapie der Urtikaria (1996) (0)
Epidemiologie der Urtikaria (2006) (0)
Ein Überblick über die Urtikaria (2020) (0)
Epidemiologie, Krankheitslast und gesundheitsökonomische Aspekte (2022) (0)
Einfluss von oral aufgenommenem Histamin auf den Hautzustand bei Patienten mit atopischer Dermatitis (2006) (0)
Urtikaria und Angioodem (2000) (0)
Use of biologicals in allergic and type 2 inflammatory diseases in the current COVID-19 pandemic/ Anwendung von biologika bei allergischen und Typ-2-entzündlichen Erkrankungen in der aktuellen COVID-19-Pandemie (2020) (0)
Contents, Vol. 193, 1996 (1996) (0)
Contents Vol. 151, 2010 (2010) (0)
Nicht medikamentöse Maßnahmen zur Vermeidung allergischer Symptome bei der Pollenallergie – eine kritische Übersicht (2021) (0)
Die Problematik der Diagnostikallergene (2022) (0)
Apfelallergie – Toleranzentwicklung durch regelmäßigen Konsum allergenarmer Äpfel. Eine Beobachtungsstudie (2020) (0)
Spezifische Immuntherapie mit Allergenen: eine wichtige Methode zur Behandlung allergischer Erkrankungen (2012) (0)
Langzeiteffekte bei gezielter Mikronährstoff-Supplementierung mit der holo-BLG-Lutschtablette bei Patienten mit Hausstaubmilben-induzierter allergischer Rhinokonjunktivitis (2022) (0)
Langfristiger Nutzen der gezielten Mikronährstoff-Supplementierung mit der holoBLG-Lutschtablette bei Hausstaubmilbenallergikern (2022) (0)
202 Differences between isolated cutaneous mast cells from non-atopic and atopic skin (2000) (0)
Gezielte Mikronährstoff-Supplementierung mit holo-BLG basierend auf dem Bauernhof-Effekt bei Patienten mit Hausstaubmilben-induzierter Rhinokonjunktivitis - erste Evaluierung in einer Allergenexpositionskammer (2021) (0)
282 Successful Treatment of Severe Nonallergic Asthma by Omalizumab. An Observation (2012) (0)
INTOLERANZREAKTION AUF SYSTEMISCHE KORTIKOSTEROIDE (1997) (0)
Weltweit geschätzt - der deutschen Allergologie eng verbunden (2022) (0)
Benzoylperoxid als Ursache einer Airborne-Kontakt-dermatitis bei einem Orthopädiemechaniker (2003) (0)
Nationale und internationale Infopoints für Fachpersonal und Patienten (2007) (0)
Bericht vom 2. DGAKI-JSA Forschungstreffen: Vielfalt allergischer Erkrankungen und deren Modulatoren (2022) (0)
Arzneimittelreaktion: Allergie vs. Intoleranz gegenüber Wirkstoffen (2020) (0)
Chronische Urtikaria als Folge einer SIT? (2001) (0)
Another PROM That Children as Well as Adults Can Use to Monitor Their Chronic Disease. (2022) (0)
Nahrungsmittelallergien : Epidemiologie in Berlin (2008) (0)
Verbesserte Diagnostik maligner Hautläsionen mittels elektronischer Dermatoskopie mit multispektraler Bildgebung (2020) (0)
Experimentelle Allergologie/Immunologie (2007) (0)
Die Testung von Äpfeln auf ihre Allergenität (2021) (0)
A novel method to generate monocyte-derived dendritic cells during coculture with HaCaT facilitates detection of weak contact allergens in cosmetics (2016) (0)
Lücken und Tücken der Kennzeichnungs-Verordnung : Die Schwierigkeit, Allergene und Pseudoallergene zu meiden (2000) (0)
Fluoreszenzoptische Bildgebung zum Nachweis einer möglichen Psoriasisarthritis im Vergleich zum muskuloskelettalen Ultraschall (2019) (0)
Efficacy and safety of biological therapies for children and adults with IgE-mediated food allergy: systematic review (2021) (0)
Kapitel 33 – Pseudoallergische Reaktionen durch Nahrungsmittel (2005) (0)
Die Möglichkeiten der Allergietherapie (2022) (0)
Schlusswort Unterschiede in den Kollektiven der chronischen Urtikaria als Erklärung abweichender Ergebnisse bei der Ursachensuche (2001) (0)
Allergische Erkrankungen (2020) (0)
17. Mainzer Allergie-Workshop (2005) (0)
Mund-Nasen-Masken zur Vermeidung von COVID-19 und Pollenallergie geeignet: eine Studie in der Expositionskammer (2021) (0)
CCR3 bindende Chemokine in eosinophilen Nasenpolypen (2005) (0)
Reply: Mast Cells in Skin Tuberculosis (1996) (0)
398 Evidence for functional in vivo interactions of human IgE with murine effector cells (1996) (0)
Contents Vol. 160, 2013 (2013) (0)
Correction. (2020) (0)
[National and international information sources for medical personnel and patients]. (2007) (0)
Brandenburger Asthma und Allergiestudie (BASAL) — erste Ergebnisse (2010) (0)
Conflicts of interests 2 The Work Under Consideration for Publication (2014) (0)
White Paper Erdnussallergie - Teil 1: Epidemiologie, Burden of Disease, gesundheitsökonomische Aspekte (2021) (0)
Atopische Dermatitis und allergische Rhinitis ‐ gibt es Co‐Effekte in der Therapie? (2012) (0)
Allergologische Versorgung vernetzt und zertifiziert (2014) (0)
Kapitel 110 – Urtikaria (2004) (0)
ARIA suggested drugs for allergic rhinitis and Quality of Life. A GA2LEN review (2007) (0)
Die Welt wird intolerant (nicht nur beim Essen): Massenhysterie oder echte Erkrankungen? (2020) (0)
6. Dermatologie (2018) (0)
ARIA Update 2008: die allergische Rhinitis und ihr Einfluss auf das Asthma: In Zusammenarbeit mit der Weltgesundheitsorganisation, GA2LEN und AllerGen (2009) (0)
Airborne Kontaktdermatitis bei einem Orthopädiemechaniker (2002) (0)
Spezifische Immuntherapie (V 33–V 38) (2000) (0)
Antiproliferative Wirkung von Histamin auf Plattenepithelkarzinom der Haut und verminderte Expression des Vascular Endothelial Growth Factor Rezeptor-2 (2018) (0)
Praktische Empfehlungen zur allergologischen Risikoabschätzung der COVID- 19-Impfung (2021) (0)
Die allergische Rhinitis und ihre Bedeutung für das Asthma: Eine BEstandsaufnahme aus deutscher Sicht (2008) (0)
Nahrungsmittelallergien durch immunologische Kreuzreaktionen / Food allergies caused by immunological cross reactions Leitlinie der Arbeitsgruppe Nahrungsmittelallergie der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAI) und des Ärzteverbandes Deutscher Allergologen (ÄDA) (S (2008) (0)
Reply to Wood et al. (2019) (0)
Barriers of use of patient-reported outcome measures (PROMs) in asthma and rhinitis care: preliminary insights from the multinational ‘PROMUSE’ study (2022) (0)
C URRENT OPINION Immunoregulation in cutaneous allergy: prevention and control (2012) (0)
Physicians' preferences in the use of PROMs during asthma and allergic rhinitis clinical approach (2022) (0)
Allergologie und Immunologie ( SGAI ) nach Übernahme des Task Force Report * der European Academy of Allergology and Clinical Immunology ( EAACI ) (2009) (0)
BARRIERS OF USE OF PROMS AMONG ALLERGISTS WHO TREAT ATOPIC DERMATITIS AND CHRONIC URTICARIA (2022) (0)
Use of biologics in allergic and type 2 inflammatory diseases in the current Covid 19 pandemic(a, b, c) (2020) (0)
Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA‐MeDALL hypothesis (2023) (0)
日光引发氧化应激中的皮肤类型差异 (2019) (0)
Sublinguale Immuntherapie (2006) (0)
Two-hours-average values of grass pollen (2013) (0)
Commentary on ''dynamic analysis of histamine-mediated attenuation of acetylcholine-induced sweating via GSK3β activation''. (2014) (0)
List of Contributors (2019) (0)
Clorfl86/RHEX Is a Negative Regulator of SCF/KIT Signaling in Human Skin Mast Cells (2023) (0)
Endotype clustering in chronic rhinosinusitis based on the chemokine expression pattern (2020) (0)

This paper list is powered by the following services:

Other Resources About Torsten Zuberbier

en.wikipedia.org

What Schools Are Affiliated With Torsten Zuberbier?

Torsten Zuberbier is affiliated with the following schools:

Torsten Zuberbier's Academic­Influence.com Rankings

Why Is Torsten Zuberbier Influential?

Torsten Zuberbier's Published Works

Published Works

Other Resources About Torsten Zuberbier

What Schools Are Affiliated With Torsten Zuberbier?

Torsten Zuberbier's AcademicInfluence.com Rankings